Role and Application of Diffusion-weighted Imaging in Evaluation of Prostate Cancer

Abstract

Introduction: Diffusion-weighted imaging (DWI) is an important part of magnetic resonance imaging (MRI) in the evaluation of specific organs, including the breast, kidney, liver, and prostate. Prostate cancer lesions are composed of tightly packed cells with reduced extracellular space, which can be visualized on DWIs as areas of restricted diffusion (i.e., high-signal intensity), with corresponding low-signal intensity on apparent diffusion coefficient (ADC) maps and low mean ADC value. Objective: The objective of this study is to identify the appropriate cutoff and mean ADC value to diagnose neoplastic prostatic lesions in central India. Materials and Methods: Sixty-six patients with suspected prostatic pathology were included in this study. All patients underwent MRI on a 1.5-T scanner with a phased-array body coil. MRIs were evaluated compared with the histopathological staging. Results:: The diagnostic accuracy of DWI in predicting malignancy was 39/41, i.e., 95.12%, which is the positive predicted value. The mean ADC for benign category was 1.14 with standard deviation (SD) of 0.14 while mean for prostatitis was 0.91 with SD of 0.26 and for carcinoma was 0.75 with SD of 0.19. The difference in the means was statistically highly significant. Conclusion: DWI demonstrates the restriction of diffusion and the reduction of ADC values in neoplastic tissue and improves the diagnostic accuracy in lesion characterization. This technique allows short acquisition time and provides high-contrast resolution between neoplastic and normal tissue. This technique can be a useful adjunct to the established dynamic contrast-enhanced-MRI.

Keywords

Apparent diffusion coefficient - diffusion-weighted imaging - prostate cancer - prostate pathologies

Publication History

Article published online:
17 June 2021

• References

• 1 Koh DM, Collins DJ. Diffusion-weighted MRI in the body: Applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1662-35
• 2 Qayyum A. Diffusion-weighted imaging in the abdomen and pelvis: Concepts and applications. Radiographics 2009; 29: 1797-810
• 3 Sato C, Naganawa S, Nakamura T, Kumada H. Miura S Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005; 21: 258-62
• 4 Van As N, Charles-Edwards E, Jackson A, Jhavar S, Reinsberg S, Desouza N. et al Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens. Br J Radiol 2008; 81: 456-62
• 5 Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 2002; 16: 196-200
• 6 Shimofusa R, Fujimoto H, Akamata H, Motoori K, Yamamoto S, Ueda T. et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005; 29: 149-53
• 7 Stadnik TW, Demaerel P, Luypaert RR, Chaskis C, Van Rompaey KL, Michotte A. et al. Imaging tutorial: Differential diagnosis of bright lesions on diffusion-weighted MR images. Radiographics 2003; 23: e7
• 8 Tartaglino LM, Flanders AE, Vinitski S, Friedman DP. Metallic artifacts on MR images of the postoperative spine: Reduction with fast spin-echo techniques. Radiology 1994; 190: 565-9
• 9 Poustchi-Amin M, Mirowitz SA, Brown JJ, McKinstry RC, Li T. Principles and applications of echo-planar imaging: A review for the general radiologist. Radiographics 2001; 21: 767-79
• 10 Gann PH. Risk factors for prostate cancer. Rev Urol 2002; 4 Suppl 5: S3-S10
• 11 Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S. Prostate cancer screening: The clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007; 25: 146-52
• 12 Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G. et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007; 189: 323-8
• 13 Kozlowski P, Chang SD, Goldenberg SL. et al. Diffusion-weighted MRI in prostate cancer-Comparison between single-shot fast spin echo and echo planar imaging sequences. Magn Reson Imaging 2008; 26: 72-6
• 14 Outwater EK, Montilla-Soler JL. Imaging of prostate carcinoma. Cancer Control 2013; 20: 161-76
• 15 Spencer JA, Chng WJ, Hudson E, Boon AP, Whelan P. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer. Br J Radiol 1998; 71: 1130-5
• 16 Singh P, Yadav MK, Singh SK, Lal A, Khandelwal N. Case series: Diffusion weighted MRI appearance in prostatic abscess. Indian J Radiol Imaging 2011; 21: 46-8
• 17 Squillaci E, Manenti G, Mancino S, Carlani M, Di Roma M. et al. MR spectroscopy of prostate cancer Initial clinical experience. Journal of Experimental and Clinical Cancer Research: CR 2005; 24: 523-30
• 18 Costouros NG, Coakley FV, Westphalen AC, Qayyum A, Yeh BM, Joe BN. et al. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging. American Journal of Roentgenology 2007; 188: 812-6